For the Inventor, By the Inventor

Enter assignee name

Daejeon, South Korea

Genomictree, Inc.

USPTO Granted Patents = 25

% Expired Patents = 16.0

EPO Patents = 11

Forward Citations = 51

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Sung Whan An (18 out of 18 patents)

Tae Jeong Oh (18 out of 19 patents)

Young Ho Moon (11 out of 11 patents)

4. Sungwhan An (5 out of 5 patents)

5. TaeJeong Oh (4 out of 4 patents)

6. Hyun Cheol Chung (2 out of 3 patents)

7. Myungsoon Kim (1 out of 2 patents)

8. Sunghwan An (1 out of 3 patents)

9. Chi-Wang Yoon (1 out of 1 patent)

10. Sung-Whan An (1 out of 1 patent)

11. Tae-Jeong Oh (1 out of 1 patent)

12. Sun-Woo Lee (1 out of 1 patent)

13. Dae-Kyung Yoon (1 out of 1 patent)

14. Myung-Soon Kim (1 out of 1 patent)

15. Suk-Kyung Woo (1 out of 1 patent)

Core Competencies:

SARS-CoV-2

Colorectal Cancer

Methylation Detection

Lung Cancer

Diagnosis Kit

Nucleic Acid Amplification

Bladder Cancer

DNA Chip

Genotyping

Precancerous Lesions

25 patents: Sort by Forward Citations

1. 12723284 - COMPOSITION FOR DIAGNOSING SARS-COV-2, KIT, AND METHOD FOR DIAGNOSING SARS-COV-2 BY USING SAME (2026-09-01),

2. 12577623 - METHOD FOR DETECTING COLORECTAL CANCER (2026-03-17),

3. 12416042 - Method for detecting methylation of SDC2 gene (2025-09-16),

4. 11268155 - Method for detecting the methylation of colorectal-cancer-specific methylation marker genes for colorectal cancer diagnosis (2022-03-08),

5. 11186866 - Method for multiplex detection of methylated DNA (2021-11-30),

6. 10767231 - Method for detecting lung cancer using lung cancer-specific methylation marker gene (2020-09-08),

7. 10428390 - Method for detecting methylation of colorectal cancer specific methylation marker gene for colorectal cancer diagnosis (2019-10-01),

8. 10428389 - Method for detecting methylation of colorectal cancer specific methylation marker gene for colorectal cancer diagnosis (2019-10-01),

9. 10428388 - Method for detecting the methylation of colorectal-cancer-specific methylation marker genes for colorectal cancer diagnosis (2019-10-01),

10. 10266900 - Method for detecting precancerous lesions (2019-04-23),

11. 10113203 - Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene (2018-10-30),

12. 10023908 - Nucleic acid amplification method using allele-specific reactive primer (2018-07-17),

13. 9850540 - Method for detecting lung cancer using lung cancer-specific methylation marker gene (2017-12-26),

14. 9797017 - Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene (2017-10-24),

15. 9783857 - Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene (2017-10-10),

Genomictree, Inc. is a biotechnology company based in Daejeon, South Korea, specializing in genomic analysis and personalized medicine. The organization focuses on developing innovative diagnostic solutions that leverage advanced genomic technologies to enhance disease detection and treatment strategies. By integrating cutting-edge research with practical applications, Genomictree aims to improve patient outcomes and contribute to the evolving landscape of healthcare through precision medicine and tailored therapeutic approaches.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Genomictree, Inc.

25 Patents

#34 in Daejeon

#525 in South Korea

#25,681 in the World

Daejeon, South Korea

Genomictree, Inc.

Forward Citations = 51

23 inventors:

Sung Whan An (18 out of 18 patents)

Tae Jeong Oh (18 out of 19 patents)

Young Ho Moon (11 out of 11 patents)

4. Sungwhan An (5 out of 5 patents)

5. TaeJeong Oh (4 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…